{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:18:47Z","timestamp":1794485927961,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03251-4","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:31:47Z","timestamp":1740411107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Alzheimer\u2019s disease with depression: clinical characteristics and potential mechanisms involving orexin and brain atrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenghong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-2241","authenticated-orcid":false,"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruidan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9056-5675","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"3251_CR1","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/gps.5556","volume":"36","author":"DKY Leung","year":"2021","unstructured":"Leung DKY, Chan WC, Spector A, Wong GHY. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36:1330\u201344.","journal-title":"Int J Geriatr Psychiatry"},{"key":"3251_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0839-1","volume":"10","author":"FS Dafsari","year":"2020","unstructured":"Dafsari FS, Jessen F. Depression-an underrecognized target for prevention of dementia in Alzheimer\u2019s disease. Transl Psychiatry. 2020;10:160.","journal-title":"Transl Psychiatry"},{"key":"3251_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamapsychiatry.2017.0658","volume":"74","author":"DC Steffens","year":"2017","unstructured":"Steffens DC. Late-life depression and the prodromes of dementia. JAMA Psychiatry. 2017;74:673\u20134.","journal-title":"JAMA Psychiatry"},{"key":"3251_CR4","doi-asserted-by":"publisher","first-page":"649103","DOI":"10.3389\/fcell.2021.649103","volume":"9","author":"F Huang","year":"2021","unstructured":"Huang F, Wu X. Brain neurotransmitter modulation by gut microbiota in anxiety and depression. Front Cell Dev Biol. 2021;9:649103.","journal-title":"Front Cell Dev Biol"},{"key":"3251_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/(SICI)1096-9861(19981228)402:4<460::AID-CNE3>3.0.CO;2-S","volume":"402","author":"C Broberger","year":"1998","unstructured":"Broberger C, De Lecea L, Sutcliffe JG, H\u00f6kfelt T. Hypocretin\/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol. 1998;402:460\u201374.","journal-title":"J Comp Neurol"},{"key":"3251_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","volume":"20","author":"CE Mahoney","year":"2019","unstructured":"Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci. 2019;20:83\u201393.","journal-title":"Nat Rev Neurosci"},{"key":"3251_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbr.2014.05.030","volume":"272","author":"J Jalewa","year":"2014","unstructured":"Jalewa J, Wong-Lin K, McGinnity TM, Prasad G, H\u00f6lscher C. Increased number of orexin\/hypocretin neurons with high and prolonged external stress- induced depression. Behav Brain Res. 2014;272:196\u2013204.","journal-title":"Behav Brain Res"},{"key":"3251_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ebiom.2017.03.043","volume":"18","author":"J Lu","year":"2017","unstructured":"Lu J, Zhao J, Balesar R, Fronczek R, Zhu QB, Wu XY, et al. Sexually dimorphic changes of hypocretin (Orexin) in depression. EBioMedicine. 2017;18:311\u20139.","journal-title":"EBioMedicine"},{"key":"3251_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12264-019-00447-9","volume":"36","author":"Y Han","year":"2020","unstructured":"Han Y, Yuan K, Zheng Y, Lu L. Orexin receptor antagonists as emerging treatments for psychiatric disorders. Neurosci Bull. 2020;36:432\u201348.","journal-title":"Neurosci Bull"},{"key":"3251_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3233\/JAD-142955","volume":"46","author":"M Boccia","year":"2015","unstructured":"Boccia M, Acierno M, Piccardi L. Neuroanatomy of Alzheimer\u2019s disease and late-life depression: a coordinate-based meta-analysis of MRI studies. J Alzheimers Dis. 2015;46:963\u201370.","journal-title":"J Alzheimers Dis"},{"key":"3251_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.neubiorev.2011.12.001","volume":"36","author":"J Li","year":"2012","unstructured":"Li J, Pan P, Huang R, Shang H. A meta-analysis of voxel-based morphometry studies of white matter volume alterations in Alzheimer\u2019s disease. Neurosci Biobehav Rev. 2012;36:757\u201363.","journal-title":"Neurosci Biobehav Rev"},{"key":"3251_CR12","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1038\/s41380-022-01772-8","volume":"27","author":"E Touron","year":"2022","unstructured":"Touron E, Moulinet I, Kuhn E, Sherif S, Ourry V, Landeau B, et al. Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network. Mol Psychiatry. 2022;27:5086\u201395.","journal-title":"Mol Psychiatry"},{"key":"3251_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"3251_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00019442-200203000-00003","volume":"10","author":"JT Olin","year":"2002","unstructured":"Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:125\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"key":"3251_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3251_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.psychres.2011.06.004","volume":"190","author":"FM Schmidt","year":"2011","unstructured":"Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, et al. Csf-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res. 2011;190:240\u20133.","journal-title":"Psychiatry Res"},{"key":"3251_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01978-9","volume":"20","author":"SY Yu","year":"2020","unstructured":"Yu SY, Lian TH, Guo P, Li LX, Ding DY, Li DN, et al. Correlations of apathy with clinical symptoms of Alzheimer\u2019s disease and olfactory dysfunctions: a cross-sectional study. BMC Neurol. 2020;20:416.","journal-title":"BMC Neurol"},{"key":"3251_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/arclin\/acz020","volume":"35","author":"RP Fellows","year":"2019","unstructured":"Fellows RP, Schmitter-Edgecombe M. Symbol digit modalities test: regression-based normative data and clinical utility. Arch Clin Neuropsychol. 2019;35:105\u201315.","journal-title":"Arch Clin Neuropsychol"},{"key":"3251_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-181217","volume":"70","author":"TH Lian","year":"2019","unstructured":"Lian TH, Zhu WL, Li SW, Liu YO, Guo P, Zuo LJ, et al. Clinical, structural, and neuropathological features of olfactory dysfunction in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2019;70:413\u201323.","journal-title":"J Alzheimers Dis"},{"key":"3251_CR20","doi-asserted-by":"publisher","first-page":"e14560","DOI":"10.1111\/cns.14560","volume":"30","author":"M He","year":"2024","unstructured":"He M, Liu Z, Lian T, Guo P, Zhang W, Huang Y, et al. Role of nerve growth factor on cognitive impairment in patients with Alzheimer\u2019s disease carrying apolipoprotein e \u03b54. CNS Neurosci Ther. 2024;30:e14560.","journal-title":"CNS Neurosci Ther"},{"key":"3251_CR21","doi-asserted-by":"publisher","first-page":"110721","DOI":"10.1016\/j.pnpbp.2023.110721","volume":"123","author":"M Amidfar","year":"2023","unstructured":"Amidfar M, Garcez ML, Kim YK. The shared molecular mechanisms underlying aging of the brain, major depressive disorder, and Alzheimer\u2019s disease: The role of circadian rhythm disturbances. Prog Neuropsychopharmacol Biol Psychiatry. 2023;123:110721.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3251_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5882","volume":"38","author":"KL Lanct\u00f4t","year":"2023","unstructured":"Lanct\u00f4t KL, Ismail Z, Bawa KK, Cummings JL, Husain M, Mortby ME, et al. Distinguishing apathy from depression: a review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders. Int J Geriatr Psychiatry. 2023;38:e5882.","journal-title":"Int J Geriatr Psychiatry"},{"key":"3251_CR23","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.jalz.2012.10.005","volume":"9","author":"PT Trzepacz","year":"2013","unstructured":"Trzepacz PT, Yu P, Bhamidipati PK, Willis B, Forrester T, Tabas L, et al. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 2013;9:S95\u2013104.e101.","journal-title":"Alzheimers Dement"},{"key":"3251_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","volume":"11","author":"C Wang","year":"2018","unstructured":"Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, et al. The orexin\/receptor system: molecular mechanism and therapeutic potential for neurological diseases. Front Mol Neurosci. 2018;11:220.","journal-title":"Front Mol Neurosci"},{"key":"3251_CR25","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","volume":"33","author":"R Fronczek","year":"2012","unstructured":"Fronczek R, van Geest S, Fr\u00f6lich M, Overeem S, Roelandse FW, Lammers GJ, et al. Hypocretin (orexin) loss in Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:1642\u201350.","journal-title":"Neurobiol Aging"},{"key":"3251_CR26","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.5665\/sleep.5846","volume":"39","author":"RS Osorio","year":"2016","unstructured":"Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, et al. Orexin-A is associated with increases in cerebrospinal fluid phosphorylated-tau in cognitively normal elderly subjects. Sleep. 2016;39:1253\u201360.","journal-title":"Sleep"},{"key":"3251_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.psychres.2011.06.004","volume":"190","author":"FM Schmidt","year":"2011","unstructured":"Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, et al. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res. 2011;190:240\u20133.","journal-title":"Psychiatry Res"},{"key":"3251_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","volume":"54","author":"RM Salomon","year":"2003","unstructured":"Salomon RM, Ripley B, Kennedy JS, Johnson B, Schmidt D, Zeitzer JM, et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry. 2003;54:96\u2013104.","journal-title":"Biol Psychiatry"},{"key":"3251_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smrv.2005.01.005","volume":"9","author":"CR Baumann","year":"2005","unstructured":"Baumann CR, Bassetti CL. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Sleep Med Rev. 2005;9:253\u201368.","journal-title":"Sleep Med Rev"},{"key":"3251_CR30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1530-0277.2010.01161.x","volume":"34","author":"I Morganstern","year":"2010","unstructured":"Morganstern I, Chang GQ, Barson JR, Ye Z, Karatayev O, Leibowitz SF. Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res. 2010;34:886\u201396.","journal-title":"Alcohol Clin Exp Res"},{"key":"3251_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1152\/jn.00001.2003","volume":"90","author":"QV Hoang","year":"2003","unstructured":"Hoang QV, Bajic D, Yanagisawa M, Nakajima S, Nakajima Y. Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol. 2003;90:693\u2013702.","journal-title":"J Neurophysiol"},{"key":"3251_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573\u201385.","journal-title":"Cell"},{"key":"3251_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1176\/appi.ajp.2016.16030319","volume":"174","author":"FL De Winter","year":"2017","unstructured":"De Winter FL, Emsell L, Bouckaert F, Claes L, Jain S, Farrar G, et al. No association of lower hippocampal volume with Alzheimer\u2019s disease pathology in late-life depression. Am J Psychiatry. 2017;174:237\u201345.","journal-title":"Am J Psychiatry"},{"key":"3251_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Holtzman DM. Biomarker modeling of Alzheimer\u2019s disease. Neuron. 2013;80:1347\u201358.","journal-title":"Neuron"},{"key":"3251_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.4088\/JCP.08m04510","volume":"70","author":"K Ritchie","year":"2009","unstructured":"Ritchie K, Jaussent I, Stewart R, Dupuy AM, Courtet P, Ancelin ML, et al. Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression. J Clin Psychiatry. 2009;70:1281\u20138.","journal-title":"J Clin Psychiatry"},{"key":"3251_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.brainres.2005.08.035","volume":"1059","author":"GJ Kirouac","year":"2005","unstructured":"Kirouac GJ, Parsons MP, Li S. Orexin (hypocretin) innervation of the paraventricular nucleus of the thalamus. Brain Res. 2005;1059:179\u201388.","journal-title":"Brain Res"},{"key":"3251_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/cne.1190","volume":"435","author":"JN Marcus","year":"2001","unstructured":"Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001;435:6\u201325.","journal-title":"J Comp Neurol"},{"key":"3251_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pbb.2009.12.016","volume":"95","author":"Y Li","year":"2010","unstructured":"Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ. Changes in emotional behavior produced by orexin microinjections in the paraventricular nucleus of the thalamus. Pharmacol Biochem Behav. 2010;95:121\u20138.","journal-title":"Pharmacol Biochem Behav"},{"key":"3251_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/brainsci10090624","volume":"10","author":"IA Georgescu","year":"2020","unstructured":"Georgescu IA, Popa D, Zagrean L. The anatomical and functional heterogeneity of the mediodorsal thalamus. Brain Sci. 2020;10:624.","journal-title":"Brain Sci"},{"key":"3251_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jad.2011.04.010","volume":"133","author":"SJ Colloby","year":"2011","unstructured":"Colloby SJ, Firbank MJ, Vasudev A, Parry SW, Thomas AJ, O\u2019Brien JT. Cortical thickness and VBM-DARTEL in late-life depression. J Affect Disord. 2011;133:158\u201364.","journal-title":"J Affect Disord"},{"key":"3251_CR41","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.biopsych.2023.05.018","volume":"94","author":"T Marawi","year":"2023","unstructured":"Marawi T, Zhukovsky P, Rashidi-Ranjbar N, Bowie CR, Brooks H, Fischer CE, et al. Brain-cognition associations in older patients with remitted major depressive disorder or mild cognitive impairment: a multivariate analysis of gray and white matter integrity. Biol Psychiatry. 2023;94:913\u201323.","journal-title":"Biol Psychiatry"},{"key":"3251_CR42","doi-asserted-by":"publisher","first-page":"1138568","DOI":"10.3389\/fnagi.2023.1138568","volume":"15","author":"DA Fleischman","year":"2023","unstructured":"Fleischman DA, Arfanakis K, Leurgans SE, Zhang S, Lamar M, Han SD, et al. Late-life depressive symptoms and white matter structural integrity within older Black adults. Front Aging Neurosci. 2023;15:1138568.","journal-title":"Front Aging Neurosci"},{"key":"3251_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.yfrne.2018.06.003","volume":"51","author":"LA Grafe","year":"2018","unstructured":"Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol. 2018;51:132\u201345.","journal-title":"Front Neuroendocrinol"},{"key":"3251_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00429-011-0343-8","volume":"217","author":"O Schmitt","year":"2012","unstructured":"Schmitt O, Usunoff KG, Lazarov NE, Itzev DE, Eipert P, Rolfs A, et al. Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct. 2012;217:233\u201356.","journal-title":"Brain Struct Funct"},{"key":"3251_CR45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.biopsych.2022.02.957","volume":"91","author":"U Gyawali","year":"2022","unstructured":"Gyawali U, James MH. Orexin (Hypocretin) signaling in the basolateral amygdala contributes to individual differences in stress sensitivity. Biol. Psychiatry. 2022;91:775\u20137.","journal-title":"Biol. Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03251-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:51:54Z","timestamp":1740412314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03251-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03251-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Board of Tiantan Hospital, Capital Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}